Validation of a Quality of Life Metric "Prolac-10"

NCT04106531 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2025-12-05

No results posted yet for this study

Summary

This is a short-term validation study of a quality of life metric "Prolac-10" for patients diagnosed with a prolactinoma, undergoing new medical therapy.

Conditions

  • Prolactinoma
  • Prolactin-Producing Pituitary Tumor
  • Pituitary Tumor
  • Prolactinoma Macroadenoma
  • Prolactinoma Microadenoma

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Douglas Hardesty, MD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2023-06-13
Completion
2023-06-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04106531 on ClinicalTrials.gov